Search
for
Sort by
Research 241–270 of 1000+
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
- Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection – results of a prospective multicenter cohort
- Immediate Post-Operative Folliculitis: A Foreign Body Reaction, Not an Infection
- Estimation of renin and D-dimer levels in women with polycystic ovary disease with or without coronavirus infection
- Tolerability of hair cleansing conditioners: a double-blind randomized, controlled trial designed to evaluate consumer complaints to the U.S. Food and Drug Administration
- An assessment of curcumin, curcumin spanlastics nanoparticles, and curcumin nanocrystals as possible drug delivery systems with antimicrobial, antioxidant, and antitumor activities
- 709 Nitric oxide-releasing topical therapeutic agent for atopic dermatitis
- Tinea Capitis: An Updated Review
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Ingestion of a dietary supplement resulting in selenium toxicity
- TWEAK-conjugated selenoviologen as a novel photosensitizer for selective wound accumulation and synergistic healing of drug-resistant bacterial infections
- Abstract 13315: Recurrent Cardiac Tamponade Due to Minoxidil Associated Drug Induced Lupus Erythematosus
- Targeting PrfA from Listeria monocytogenes: a computational drug repurposing approach
- Hair Drug Testing Routine in Many Clinical and Forensic Applications
- Pathophysiological and Pharmaceutical Considerations for Enhancing the Control of Sarcoptes scabiei in Wombats Through Improved Transdermal Drug Delivery
- Clinico-etiological and histopathological correlation in erythroderma: In a tertiary care hospital of Eastern Odisha
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin
- Cutaneous Side Effects of Oral Contraceptives
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Nano drug delivery systems: a promising approach to scar prevention and treatment
- Isoniazid-induced alopecia
- Combination of an engineered <i>Lactococcus lactis</i> expressing CXCL12 with light‐emitting diode yellow light as a treatment for scalded skin in mice
- Hair Follicle Targeting with Nanoparticles
- Expression of lipid-protein gene PLP2 in Liaoning cashmere goat
- Staphylococcus lugdunensis and Trichophyton tonsurans Infection in Synthetic Hair Implants.
- Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
- Fast-Embeddable Grooved Microneedles by Shear Actuation for Accurate Transdermal Drug Delivery